학술논문
Real-World Efficacy of First-Line Pembrolizumab in Patients With Advanced or Recurrent Non–Small-Cell Lung Cancer and High PD-L1 Tumor Expression
Document Type
Article
Author
Source
In: Clinical Lung Cancer . (Clinical Lung Cancer, September 2020, 21(5):e366-e379)
Subject
Language
English
ISSN
19380690
15257304
15257304